Table 2.
The CDT procedure characteristics.
| Variables | N = 14 (100%) |
|---|---|
| PE location | |
| Bilateral | 14 (100) |
| Saddle and main arteries | 2 (14.3) |
| Lobar and segmental | 9 (64.3) |
| Segmental and subsegmental | 3 (21.4) |
| Clot clearance | |
| >90% | 2 (14.3) |
| 50–90% | 8 (57.1) |
| <50% | 4 (28.6) |
| Access site | |
| Femoral | 13 (92.9) |
| Jugular | 1 (7.1) |
| Time from PE diagnosis to CDT (days) | 2.5 (1–13.5) |
| CDT duration time (min) | 72 (60–100) |
| Radiation dose (mGy) | 159 (113–273) |
| Fluoroscopy time (min) | 24.5 (20–36) |
| Contrast use (ml) | 207 (150–275) |
| Amount of blood loss (ml) | 300 (290–325) |
| AC type before procedure | |
| UFH | 9 (64.3) |
| LMWH | 5 (35.7) |
| Length of hospitalization (days) | 6 (4–7) |
Values are n (%) or median (IQR). CDT = catheter-directed mechanical aspiration thrombectomy, UFH = unfractionated heparin, and LMWH = low molecular weight heparin.